Cell & gene therapy testing

At RSSL, our pharmaceutical experience enables us to create tailored analytical solutions to support the development and manufacturing of innovative cell and gene therapies.


The last few years have seen significant developments in the field of Advanced Therapy Medicinal Products (ATMPs), leading to the innovation of next-generation therapeutics for previously untreatable and often life-limiting illnesses, ranging from genetic disorders to cancer.


However, the lack of single, all-purpose analytical solutions, combined with the rapidly evolving regulatory environment, can make the development and manufacturing of these novel therapies challenging.


To support the delivery of innovative cell and gene therapies, RSSL offers integrated analytical services that can support early-stage development through to IND applications, commercial manufacturing and product release.


Q Exactive RD 4676 HR Shutterstock 1283997949 (1) Gettyimages 1023147086

Contact us

Need to get in touch? Either complete the enquiry form or call us:

Switchboard: +44 (0)118 918 4000

Customer Services: +44 (0)118 918 4076

We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.